My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 231

    1.

    Breaking the camel's back: multicenter clinical trials and local institutional review boards.

    Burman WJ, Reves RR, Cohn DL, Schooley RT.

    Ann Intern Med. 2001 Jan 16;134(2):152-7.PMID: 11177319 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    American Society of Clinical Oncology policy statement: oversight of clinical research.

    American Society of Clinical Oncology.

    J Clin Oncol. 2003 Jun 15;21(12):2377-86. Epub 2003 Apr 29.PMID: 12721281 [PubMed - indexed for MEDLINE]Related articles

    3.

    Problematic variation in local institutional review of a multicenter genetic epidemiology study.

    McWilliams R, Hoover-Fong J, Hamosh A, Beck S, Beaty T, Cutting G.

    JAMA. 2003 Jul 16;290(3):360-6.PMID: 12865377 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Changing the paradigm: new directions in federal oversight of human research.

    Koski G.

    J Pediatr Gastroenterol Nutr. 2003 Nov-Dec;37 Suppl 1:S2-6.PMID: 14685070 [PubMed - indexed for MEDLINE]Related articles

    5.

    Current issues surrounding women and minorities in drug trials.

    Wermeling DP, Selwitz AS.

    Ann Pharmacother. 1993 Jul-Aug;27(7-8):904-11.PMID: 8364277 [PubMed - indexed for MEDLINE]Related articles

    6.

    Institutional review boards: a crisis in confidence.

    Levine RJ.

    Ann Intern Med. 2001 Jan 16;134(2):161-3. No abstract available. PMID: 11177321 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.

    Bramstedt KA, Kassimatis K.

    Clin Invest Med. 2004 Dec;27(6):316-23.PMID: 15675112 [PubMed - indexed for MEDLINE]Related articles

    8.

    Variability among institutional review boards' decisions within the context of a multicenter trial.

    Silverman H, Hull SC, Sugarman J.

    Crit Care Med. 2001 Feb;29(2):235-41.PMID: 11246299 [PubMed - indexed for MEDLINE]Related articles

    9.

    Variation in institutional review board responses to a standard protocol for a multicenter clinical trial.

    Stair TO, Reed CR, Radeos MS, Koski G, Camargo CA; MARC Investigators. Multicenter Airway Research Collaboration.

    Acad Emerg Med. 2001 Jun;8(6):636-41.PMID: 11388939 [PubMed - indexed for MEDLINE]Related articles

    10.

    Current issues in clinical research and the development of new pharmaceuticals.

    Goldhammer A.

    Account Res. 2001;8(4):283-91.PMID: 12481798 [PubMed - indexed for MEDLINE]Related articles

    11.

    IRBs and monitoring the safety of clinical trials.

    Maloney DM.

    Hum Res Rep. 2003 Jan;18(1):3. No abstract available. PMID: 12755095 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinical trial monitoring: hit or miss?

    Cohen J.

    Science. 1994 Jun 10;264(5165):1534-7. No abstract available. PMID: 8202707 [PubMed - indexed for MEDLINE]Related articles

    13.

    Research consent by adolescent minors and institutional review boards.

    Mammel KA, Kaplan DW.

    J Adolesc Health. 1995 Nov;17(5):323-30.PMID: 8924437 [PubMed - indexed for MEDLINE]Related articles

    14.

    Duke's hazards. Did medical experiments put patients needlessly at risk?

    Kaplan S, Brownlee S.

    US News World Rep. 1999 May 24;126(20):66-8, 70. No abstract available. PMID: 10387890 [PubMed - indexed for MEDLINE]Related articles

    15.

    Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.

    Gordon VM, Sugarman J, Kass N.

    IRB. 1998 Jan-Feb;20(1):1-5. No abstract available. PMID: 11655324 [PubMed - indexed for MEDLINE]Related articles

    16.

    IRBs search for answers and support during a time of institutional change.

    Phillips DF.

    JAMA. 2000 Feb 9;283(6):729-30. No abstract available. PMID: 10683041 [PubMed - indexed for MEDLINE]Related articles

    17.

    An Institutional Review Board dilemma: responsible for safety monitoring but not in control.

    DeMets DL, Fost N, Powers M.

    Clin Trials. 2006;3(2):142-8.PMID: 16773956 [PubMed - indexed for MEDLINE]Related articles

    18.

    Toward protecting the safety of participants in clinical trials.

    Califf RM, Morse MA, Wittes J, Goodman SN, Nelson DK, DeMets DL, Iafrate RP, Sugarman J.

    Control Clin Trials. 2003 Jun;24(3):256-71.PMID: 12757992 [PubMed - indexed for MEDLINE]Related articles

    19.

    Economies of scale in institutional review boards.

    Wagner TH, Cruz AM, Chadwick GL.

    Med Care. 2004 Aug;42(8):817-23.PMID: 15258484 [PubMed - indexed for MEDLINE]Related articles

    20.

    New guidance on reviews by central institutional review boards (IRBs).

    Maloney DM.

    Hum Res Rep. 2005 May;20(5):1-2. No abstract available. PMID: 16175714 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity